key: cord-0803133-gkebavz5 authors: Badkoubeh, Roya Sattarzadeh; Almassi, Nooshin; Farahani, Maryam Moshkani; Movassaghi, Naser; Khosravi, Arezoo; Mirdamadi, Ahmad; Kamali, Monireh; Manshouri, Shirin; Tabrizi, Mehrnoush Toufan; Farrashi, Melody; Samiei, Niloufar title: The Iranian Society of Echocardiography (ISE) Statement on Performing Echocardiography During the COVID-19 Pandemic date: 2020-05-08 journal: Curr Probl Cardiol DOI: 10.1016/j.cpcardiol.2020.100620 sha: 87d2d6df47e379f8b76bc3ad70f03f3a48908ca9 doc_id: 803133 cord_uid: gkebavz5 Corona virus disease 2019(COVID-19) pandemic has caused a significant burden on the global health system. Considerable cardiovascular involvement has been reported among COVID-19 patients with higher ICU admission and mortality rates among patients with cardiovascular comorbidities. Consequently, diagnostic cardiovascular evaluations such as echocardiography are a crucial part of the disease management. On the other hand, providing safety for the patients and the healthcare personnel is a matter of great concern in the pandemic state. In this document, we have provided recommendations on performing echocardiography in hospital echocardiography labs and outpatient echocardiography clinics during the current COVID-19 (Coronavirus disease of 2019) outbreak. Transthoracic echocardiography (TTE), stress echocardiography, and transesophageal echocardiography (TEE) are procedures with close contact with the patient, with TEE also considered as a droplet and aerosol generating procedure. The recommendations herein are similar for hospital echocardiography labs and outpatient echocardiography clinics. However, in case of self-check in of suspicious or confirmed cases to out-patient clinics, echocardiography should not be performed and the patients should immediately be referred to the nearest medical center assigned for the triage of COVID-19 patients. Recommendations are classified into 2 categories based on patient characteristics: 1) Asymptomatic(non-suspicious) 2) Suspicious for COVID-19, and patients with confirmed COVID-19. -All elective ambulatory and routine follow-up visits should be delayed, and nonurgent echocardiography requests should be postponed. -Triage sections should be separated from patients by engineering control measures such as glass windows or temporary plexiglass barriers in order to reduce the risk of exposure. -Triage of patients with respiratory symptoms should be prioritized. -All patients referred to echocardiography labs should be evaluated for the following (1): Detailed history of fever, cough, sore throat, chills, diarrhea, headache, malaise and new dyspnea in the past few days. • Residence in or recent travel to high-risk areas in the past 2 weeks. • History of close contacts with suspicious or confirmed COVID-19 patients in the past two weeks. After the initial evaluation, the patient's temperature should be checked. Significant fever is defined as an oral temperature of more than 37.3 °C AM, 37.8 °C PM. -Patients should not gather in the waiting room. For instance, it is advisable that they remain outside the hospital until they are called in for their appointment. Note that presence of patient companions should be strongly prohibited unless their presence is somehow essential. -If feasible, a separate waiting area should be dedicated for patients with suspicion for and those with a definite diagnosis of COVID-19. -Patients or their companions/caregivers should comply with social distancing and keep a distance of 6 feet (2 meters) while seating in the room. -Patients and their companions/caregivers, as well as healthcare personnel, should use surgical masks while in the waiting room/triage area. They should also be advised to avoid touching their masks. -Hand sanitizer, wipes, disinfectants and tissues should be adequately at hand. -Special hazardous infectious material litter bins should be readily available for the disposal of guidelines. This includes high touch areas in the room such as door knobs, light switches, key board, computer screen, patient bed and surfaces. -All disposable materials such as gowns, surgical masks, bed sheets, and O 2 masks should be discarded in specified bins. Reusable equipment such as face shield should be wiped properly. -Patients are advised to perform hand hygiene with Alcohol Based Hand Rub (ABHR before entering the room. -If patients leave the room during the echocardiography examination for any reason, it is necessary that they once again disinfect their hands upon re-entering the room. -All patients are advised to wear surgical face masks. The use of surgical gowns is not mandatory unless the physician deems it beneficial or the patient's outfit is unclean. -Physicians should perform hand hygiene with ABHR (or with soap and water for at least 20 seconds) both before entering the room and after performing echocardiography. -The echocardiographer and other healthcare personnel in the room should choose PPE based on the patient and procedure type. -TEE is an aerosol and droplet-generating procedure. Therefore, use of advanced PPE, comprised of long-sleeved surgical fluid-repellent gowns, nitrile or latex gloves (which should cover the sleeve cuffs of the gown), respirator N95, N99 or FFP2, FFP3 masks, and protective goggles or ideally face shields, is recommended to the echocardiographer, the anesthetic technician, and the nurse in charge whom are in close contact (within 2meter distance) with the patient. -Valsalva and cough maneuvers should be strictly avoided. (Studies for the evaluation of the patent foramen ovale should be postponed.) Patients -Vis-à-vis suspicious/definite COVID-19 patients, it is strongly recommended that echocardiography not be performed in outpatient clinics or offices. -Echocardiography should be performed only in case of evident indication. It is preferred to use advanced PPE as noted above, consisting of long-sleeved surgical fluidrepellent gowns, nitrile or latex gloves (which should cover the sleeve cuffs of the gown), respirator N95, N99 or FFP2, FFP3 masks, and protective goggles or ideally face shields (7) Full PPE is also acceptable as the procedure is a non-aerosol producing procedure. -Enhanced PPE, comprised of consisting of long-sleeved surgical fluid-repellent gowns or protective coveralls, double nitrile or latex gloves (which should cover the sleeve cuffs of the gown), respirator N95, N99 or FFP2, FFP3 masks, and protective goggles or ideally face shields, shoe covers, and head covering, is strongly urged. Note that no skin should be exposed. -It is recommended to use nylon covers for TEE probes in suspicious/confirmed COVID-19 patients. -Bedside TEE on intubated patients with COVID-19 should be performed in an isolated room or if not possible, in a special ward for COVID-19 patients. -Recommendations regarding the cleaning of echocardiography equipment are presented later. There have been reports of significant cardiovascular involvement among COVID-19 patients. An earlier study reported rates of 7.2% for myocardial injury, 8.7% for cardiogenic shock, and 16.7% for arrhythmias in this group of patients. (8) Furthermore, ICU admission and mortality rates appear to be higher among COVID-19 patients with previous cardiovascular comorbidities. This comprises a significant number of patients as a meta-analysis on 1527 COVID-19 patients reported a prevalence rate of 16.4% for cardiovascular disease. (9) (10) (11) The precise indication of the echocardiography and the required data in that regard should be considered prior to the exam. A goal oriented and rapid study should then be performed, acquiring only the necessary views in order to minimize the exam duration as much as possible. Recommended indications for performing echocardiography are as follows: -It is also reasonable to perform echocardiography at the discretion of the consultant cardiologist while considering the appropriateness criteria. -As TEE bears a high risk of transmission due to droplet and aerosol generating properties, it is highly recommended to perform the procedure only if it is vital, concerning the diagnostic or treatment plan of the patient. • A CT scan should be performed before echocardiography in patients presenting with fever and suspicious of infective endocarditis if there are respiratory symptoms, O 2 saturation levels of less than 93%, or lymphopenia. -The person in charge of disinfection should use advanced PPE. -Monitors, probes, probe holders, control panels, ECG leads and cables, and plastic covers of echocardiography machines are the parts amenable to disinfection. -All parts of the echocardiography machine should be cleaned from any external debris and then dried before disinfection. -Echocardiography machines should not be exposed to high UV sources, including direct sunlight. -Ultrasonic cleaning is not recommended. -It is highly recommended to choose the compatible disinfectant based on the manufacturer's recommended list. -Disinfectants containing surfactants, methanol, ethanol, benzyl or methyl alcohol, bleaches, methyl or ethylparaben, polyethylene glycol, oil-based lotions, acetone, ammonia, iodine compounds, and solutions with a pH of 5 or greater may cause damage to the transducer and their use should be avoided. suspicious/definite COVID-19 patients, cleaning should be performed right after echocardiography is done. -This type of disinfection is used when the probe is in contact with intact skin and not mucosa. -The probe should be disconnected from the unit. -The coupling gel and any external debris should be wiped with a soft cloth. -The probe and its cable should then be wiped with a soft cloth sprayed with a recommended disinfectant liquid. Note that the liquid should not be sprayed on the probe. -Cleaning the probe should be performed with caution so as not to cause any damage to the surface of the lens. -The cleansing material should be wiped off the probe after about 30 seconds to prevent any damage. -Sodium hypochlorite (concentration ≈ 0.6%), quaternary ammonium (< 0.8% concentration), accelerated hydrogen peroxide (maximum concentration = 0.5%), and alcohol-based solutions (maximum concentration should not exceed 70%) are some of the low-level disinfectants that are generally compatible for use. -Note that the only parts that may be cleaned with isopropyl alcohol are the connector housing, the transducer housing, and the lens of the TTE probe and the connector housing and the control housing of the TEE probe. -This type of disinfection, which is considered after mucosal contact, results in the elimination of all microorganisms except for a few bacterial spores. -Common high-level disinfectants include glutaraldehyde, ortho-phthalaldehyde, hydrogen peroxide, and peracetic acid. It is highly recommended that the manufacturer's recommendations be followed for the type of disinfection. -The probe should be disconnected from the unit. -The probe surface should be dried and wiped with a soft cloth. -The exposed part is then placed in the specified germicide for the desired duration as recommended by the manufacturer. -The germicide is thereafter rinsed from the probe. It can be dried with a towel or air-dried afterward. (12, 13) The rinsing of the TEE probe can be repeated up to 3 times to make sure that there is no residual disinfectant on the probe since it can cause skin/mucosal irritation. • We recommend high-level disinfection of the probe after both TTE and TEE on suspicious/confirmed COVID-19 patients. Iranian health ministry. National flowchart of dignosis and treatment of COVID-19 in outpatient and inpatient settings 2020 Natural ventilation for reducing airborne infection in hospitals Recommended Guidance for Extended Use and Limited Reuse of N95 Filtering Facepiece Respirators in Healthcare Settings Sequence for Donning Personal Protective Equipment (PPE) Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected 2020 Journal of the American College of Cardiology. 2020. 7. WHO Authors. Rational use of personal protective equipment for coronavirus disease (COVID-19): interim guidance Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic N-terminal pro-B-type natriuretic peptide in the emergency department: The ICON-RELOADED study The authors would like to acknowledge Neda Behzadnia MD, Ahmad Amin MD and Alireza Akhzarian Kashani for their valuable comments. Also we would like to thank Pedram Amoozadeh and Hengame Meschi for their contribution.